Literature DB >> 28360598

Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.

Nihal Işik1, Nüket Yildiz Manukyan2, İlknur Aydin Cantürk1, Fatma Candan1, Ayşen Ünsal Çakmak1, Güher Saru Han Direskeneli3.   

Abstract

INTRODUCTION: It is well recognized that both genetic and environmental factors play an important role in the pathogenesis of multiple sclerosis (MS). Immune pathogenesis of MS focuses on pathogenic CD4+ T lymphocytes. CD4+CD25+ regulatory T cells have suppressive function in this cell group. FOXP3 (forkhead boxP3) transcription factor is a key structure in the development and function of regulatory cells. Functional alterations in FOXP3 gene expression have been observed in various autoimmune diseases.
METHODS: We screened a non-synonymous coding single nucleotide polymorphism (exon +2710 C/T) (rs2232369) of human FOXP3 gene in 148 MS patients (118 with Relapsing Remitting MS, 30 with Secondary Progressive MS) and 102 age- and sex-matched healthy controls. The association of polymorphisms with susceptibility, and course of the disease was evaluated.
RESULTS: We could not detect any single nucleotide polymorphism in MS patients, however, polymorphic allele was detected in 3% of the control group. Consequently, a genetic association between the FOXP3 gene polymorphism and MS was not revealed.
CONCLUSION: The distribution of this polymorphism has not been screened in any other MS populations before. Although we could not succeed to find any association between susceptibility to MS and screened FOXP3 gene polymorphisms, we suggest that this particular polymorphism is not appropriate for these kind of studies in the future.

Entities:  

Keywords:  FOXP3; Multiple Sclerosis; genotype; polymorphism

Year:  2014        PMID: 28360598      PMCID: PMC5370262          DOI: 10.4274/npa.y7098

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  30 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

Review 2.  Foxp3 and natural regulatory T cells: key to a cell lineage?

Authors:  Fred Ramsdell
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 3.  New insights into the immunogenetics of multiple sclerosis.

Authors:  J R Oksenberg; S L Hauser
Journal:  Curr Opin Neurol       Date:  1997-06       Impact factor: 5.710

Review 4.  FOXP3 acts as a rheostat of the immune response.

Authors:  Hans D Ochs; Steven F Ziegler; Troy R Torgerson
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

Review 5.  The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.

Authors:  K C O'Connor; A Bar-Or; D A Hafler
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 6.  Genetics of multiple sclerosis.

Authors:  David A Dyment; George C Ebers; A Dessa Sadovnick
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

7.  Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.

Authors:  Prabhakar Putheti; Asa Pettersson; Mats Soderstrom; Hans Link; Yu Min Huang
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

8.  CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

Authors:  Moa Fransson; Elena Piras; Joachim Burman; Berith Nilsson; Magnus Essand; Binfeng Lu; Robert A Harris; Peetra U Magnusson; Eva Brittebo; Angelica S I Loskog
Journal:  J Neuroinflammation       Date:  2012-05-30       Impact factor: 8.322

9.  No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population.

Authors:  Patrizia Zavattari; Elisabetta Deidda; Maristella Pitzalis; Barbara Zoa; Loredana Moi; Rosanna Lampis; Daniela Contu; Costantino Motzo; Paola Frongia; Efisio Angius; Mario Maioli; John A Todd; Francesco Cucca
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  1 in total

1.  FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Bruna Lo Sasso; Giuseppe Salemi; Caterina Maria Gambino; Paolo Ragonese; Giuseppina Candore; Anna Maria Ciaccio; Rosaria Vincenza Giglio; Giulia Bivona; Matteo Vidali; Marcello Ciaccio
Journal:  Brain Sci       Date:  2021-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.